Counting the costs of overweight and obesity: modeling clinical and cost outcomes

Authors:

Abstract
Objective: To quantify changes in clinical and cost outcomes associated with increasing levels of body mass index (BMI) in a US setting.Research methods and procedures: A semi-Markov model was developed to project and compare life expectancy (LE), quality-adjusted life expectancy (QALE) and direct medical costs associated with distinct levels of BMI in simulated adult cohorts over a lifetime horizon. Cohort definitions included age (20–65 years), gender, race, and BMI (24–45 kg m−2). Cohorts were exclusively male or female and either Caucasian or African-American. Mortality rates were adjusted according to these factors using published data. BMI progression over time was modeled. BMI-dependent US direct medical costs were derived from published sources and inflated to year 2004 values. A third party reimbursement perspective was taken. QALE and costs were discounted at 3% per annum.Results: In young Caucasian cohorts LE decreased as BMI increased. However, in older Caucasian cohorts the BMI associ...

This publication has 23 references indexed in Scilit: